Drawing for EVERFILL

USPTO serial 88219381

EVERFILL

Reviewed by CopyMark Law Group

Reg. 6285602Status 700Renewal
Filing date
Status date
Registration date
Mar 9, 2021
Examiner
WATTS-FITZGERALD, CAITLIN C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EVERFILL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Geza C. Ziegler Jr.

Geza C. Ziegler Jr. ZIEGLER IP LAW GROUP LLC.3135 Easton TurnpikeSHU i-Hub, W-256Fairfield, CT 06825

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cosmetic preparations, namely, non-medicated cosmetic preparations formed from extracts derived from human and animal tissue sold as components of cosmetics; Non-medicated cosmeticsACTIVE—
005Cell-free tissue preparations, namely, human and animal adipose tissue extracts for regeneration of skin and and subcutaneous tissue for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Biological tissue for implantation, namely, biological skin tissue intended for subsequent implantation; Skin grafts; Biological tissue cultures for medical purposes; Human allograft tissue; Pharmaceutical and medicinal preparations, namely, pharmaceutical and medicinal extracts in the nature of human and animal adipose tissue extracts for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Synergists and adjuvants for living tissues for medical purposes; Synergists and adjuvants for live organs and tissues for medical surgical purposes; Processed human donor skin for the replacement of soft tissue; Medicinal healthcare preparations in the nature of human and animal adipose tissue extract for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Pharmaceutical preparations for treating skin disorders; Skin care preparations for medical use; Pharmaceutical preparations for use in tissue transplantation, specifically, for regeneration of skin; Pharmaceutical preparations for the regeneration of tissue; Adhesive bandages for skin wounds; Medical dressings; Pharmaceuticals and natural remedies all in the nature of human and animal adipose tissue extracts for regeneration of tissue for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Preparations for cleansing the skin for medical use; Adhesive skin patches for medical use, namely, medicinal patches for the treatment of skin defects; Medicated skin care preparationsACTIVE—
010Medical equipment and accessory equipment, namely, medical devices for the treatment of skin defects, specifically, hydrogels; Artificial skin replacing membranes, namely, artificial skin for replacing blemished, scarred, disfigured or unhealthy skin in order to treat skin defects; Sutures; Wound closing materials and products, namely, medical devices for closing wounds; Artificial skin implants; Transplant sutures for use in surgery; none of the abovementioned products being related to extracorporeal blood treatment and renal insufficiency; Medical applicators, namely, injection syringes, injection needles and cathetersACTIVE—
044Human healthcare; Medical services; Dermatological services for treating skin conditions; Medical services for treatment of the skin; Medical services for the care of the skin; Medical diagnostic reporting, monitoring, advice, consultancy, and information relating to any of the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 9, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 18, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 18, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 22, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 22, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 2, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 26, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 13, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2019ALIEASSIGNED TO LIE—
Sep 5, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2019DOCKASSIGNED TO EXAMINER—
Dec 28, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance